Synthesis, evaluation, and docking study of adamantyl-1,3,4-oxadiazol hybrid compounds as CaMKIIδ kinase inhibitor
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Chemical Research"
DOI: 10.1177/17475198241262467
Abstract: This study revealed a new inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII), a crucial factor in cardiovascular disease and hypertension. The study focuses on the bioactivity compounds that combine adamantane/1,3,4-oxadiazole, potentially inhibiting CaMKIIδ. Various adamantyl-1,3,4-oxadiazole… read more here.
Keywords: camkii kinase; evaluation docking; synthesis evaluation; inhibitor ... See more keywords